Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.150 GBX | 0.00% |
|
-3.08% | -55.63% |
29/05 | Poolbeg Pharma PLC - Shareholder/Analyst Call | |
27/05 | Poolbeg Pharma shares up after US FDA orphan drug designation | AN |
Main competitors
Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
- | - | -3.18x | 2.63x | - | -2.74x | -2.56x | 2.98Cr | ||
-.--% | -.--% | 47.59x | 5.19x | 8.06x | 35.91x | 37.13x | 3.33TCr | ||
1.7% | 1.94% | 17.08x | 2.99x | 4.19x | 11.45x | 13.41x | 2.78TCr | ||
-.--% | -.--% | -23.67x | 1.28x | 5.91x | -9.65x | -8.96x | 2.75TCr | ||
-.--% | -.--% | -57.55x | - | - | -57.84x | -56.85x | 1.84TCr | ||
-.--% | -.--% | -18.06x | 53.6x | 40.28x | -19.81x | -19.57x | 1.83TCr | ||
-.--% | -.--% | 24.56x | 2.04x | 4.3x | 12.49x | 15.98x | 1.34TCr | ||
-.--% | -.--% | 13.28x | 2.08x | 2.61x | 7.36x | 7.95x | 1.32TCr | ||
-.--% | -.--% | 1970.31x | 13.05x | 25.43x | 290.64x | 1273.32x | 1.26TCr | ||
-.--% | -.--% | 19.13x | 4.31x | 4.6x | 13.23x | 13.76x | 1.2TCr | ||
-.--% | -.--% | -117x | 25.47x | 36.34x | -197.36x | -115.95x | 1.02TCr | ||
-.--% | -.--% | -42.57x | 7.32x | 6.6x | -54.91x | -46.11x | 727.11Cr | ||
-.--% | -.--% | -24.17x | 13.09x | 9.34x | -16.53x | -18.99x | 685.17Cr | ||
0.44% | -.--% | 29.76x | 5.41x | 9.88x | 30.96x | 33.5x | 595.32Cr | ||
-.--% | -.--% | -16.46x | 6.6x | - | -17.56x | -15.19x | 585.24Cr | ||
0.31% | 0.41% | 57.89x | 1.94x | 3.52x | 15.99x | 29.22x | 581.49Cr | ||
-.--% | -.--% | -36.84x | 21.52x | 15.73x | -65.85x | -41.68x | 493.85Cr | ||
Average | 0.15% | 0.15% | 108.24x | 10.53x | 12.63x | -1.42x | 64.61x | 1.31TCr | |
Weighted average by Cap. | 0.23% | 0.25% | 107.68x | 10.41x | 12.01x | 5.47x | 66.50x |
- Stock Market
- Equities
- POLB Stock
- Sector Poolbeg Pharma PLC
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition